Lead study author and Scientia Professor Vlado Perkovic, Provost at UNSW Sydney, said the benefits of semaglutide for those with type 2 diabetes and chronic kidney disease were greater than expected
GLP-1 agonists have emerged as a popular option for supporting weight loss, but many people wonder if they need to use these medications forever
Pens and compounded vials have different formulations, different excipients, and different stability data
The Bridge gives them one for the next 18 months
Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu, China
GLP-1 Drugs & Malnutrition: Why Litigation Is Coming Introduction The rise of GLP-1 receptor agonists (Ozempic, Wegovy, Saxenda, Mounjaro) has transformed treatment for obesity and diabetes